Understanding SARMs in 2026: What Current Research Says

By Your Health Magazine Contributor

Your Health Magazine Contributor

More Health News & Research Articles

Understanding SARMs in 2026: What Current Research Says

Selective Androgen Receptor Modulators (SARMs) continue to generate interest among researchers and fitness communities in 2026. These compounds are designed to selectively bind to androgen receptors, with the goal of promoting anabolic activity in specific tissues such as muscle and bone while minimizing effects on other organs.

Although several SARMs have been investigated in preclinical and early clinical studies, most remain experimental compounds and are not approved for muscle-building or athletic performance enhancement. Research is ongoing, and many questions regarding their long-term safety and effectiveness remain unanswered.

This article summarizes current research on several commonly discussed SARMs and highlights what is currently known about their characteristics and potential safety considerations.

RAD-140 (Testolone)

RAD-140, also known as Testolone, is among the most frequently discussed SARMs in scientific literature and bodybuilding communities. Preclinical studies have investigated its anabolic activity and tissue-selective androgen receptor binding, suggesting potential applications that have attracted research interest.

Despite promising laboratory findings, evidence from human clinical studies remains limited. Researchers continue to investigate its pharmacological profile, while long-term safety data are still lacking.

AC-262 (Accadrine)

AC-262, often referred to as Accadrine, is another investigational SARM that has received attention for its relatively selective receptor activity. Compared with some other SARMs discussed online, it is generally described as having a milder anabolic profile, although comprehensive human research remains limited.

As with all investigational SARMs, available information is based largely on early-stage research, and additional clinical studies are needed to better understand both potential benefits and safety considerations.

RAD-150

RAD-150 is structurally related to RAD-140 and has been modified with a benzoate ester. According to available discussions and preliminary reports, this modification may extend the compound’s duration within the body compared with RAD-140.

However, published clinical evidence evaluating RAD-150 remains limited. Much of the available information originates from industry discussions rather than large-scale peer-reviewed human studies, making further research necessary before definitive conclusions can be drawn.

Other Commonly Discussed SARMs

Several additional SARMs continue to appear in research publications and discussions within the fitness community.

LGD-4033 (Ligandrol)

LGD-4033 is among the better-studied SARMs. Early clinical research has examined its effects on lean body mass in healthy individuals, providing more human data than many newer compounds. Nevertheless, researchers emphasize that additional long-term studies are required to fully evaluate its safety profile.

S-23

S-23 is another investigational selective androgen receptor modulator that has demonstrated strong anabolic activity in preclinical research. Human data remain extremely limited, and its overall safety profile has not been established through large clinical trials.

Safety Considerations

Although SARMs are frequently discussed online, it is important to recognize that most remain investigational compounds.

Current research highlights several important considerations:

• Long-term safety has not been fully established.
• Hormonal suppression may occur with some compounds.
• Product quality can vary significantly between manufacturers.
• Independent laboratory testing may help verify product identity and purity.
• Regulatory status differs between countries, and consumers should understand applicable laws before purchasing or using these compounds.

Individuals considering SARMs should consult qualified healthcare professionals and rely on evidence-based information rather than marketing claims.

Ongoing Research

Scientific interest in SARMs continues because of their potential applications beyond sports and bodybuilding. Researchers are investigating whether selective androgen receptor modulation could contribute to future treatments for conditions involving muscle wasting, osteoporosis, and other disorders associated with reduced muscle mass.

However, these potential medical applications remain under investigation, and additional clinical evidence is required before broader conclusions can be made.

Conclusion

SARMs remain an active area of scientific research in 2026. Compounds such as RAD-140, AC-262, RAD-150, LGD-4033, and S-23 continue to be studied for their pharmacological properties and possible therapeutic applications.

As research progresses, readers should focus on evidence-based information, understand the experimental nature of these compounds, and recognize the importance of product transparency, quality assurance, and independent laboratory testing when evaluating available information.

Frequently Asked Questions

What are SARMs?

SARMs (Selective Androgen Receptor Modulators) are experimental compounds designed to selectively activate androgen receptors in certain tissues. Most are still being investigated and are not approved for bodybuilding purposes.

Which SARMs have received the most research?

Among commonly discussed compounds, LGD-4033 and RAD-140 have been the subject of several published studies. Nevertheless, additional human research is still needed for all SARMs.

Are SARMs approved medications?

The regulatory status of SARMs varies by country. Many remain investigational compounds and are not approved for recreational muscle-building use.

Why is independent laboratory testing important?

Because product quality may differ between manufacturers, independent third-party testing can provide additional transparency regarding product identity and purity.

References:

1. Miller, C. P., Shomali, M., Lyttle, C. R., et al. (2011). Design, Synthesis, and Preclinical Characterization of the Selective Androgen Receptor Modulator (SARM) RAD140. ACS Medicinal Chemistry Letters, 2(2), 124-129. https://doi.org/10.1021/ml1002508
2. O’Connor, T. (2026). RAD-150 vs. RAD-140: Which is the Superior SARM?. Inside Bodybuilding 
3. Basaria, S., Collins, L., Dillon, E. L., Orwoll, K., Storer, T. W., Miciek, R., Ulloor, J., Zhang, A., Eder, R., Zientek, H., Gordon, G., Kazmi, S., Sheffield-Moore, M., & Bhasin, S. (2013). The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. The journals of gerontology. Series A, Biological sciences and medical sciences, 68(1), 87–95. https://doi.org/10.1093/gerona/gls078